Eads & Heald Wealth Management Increases Stock Position in CVS Health Corp (NYSE:CVS)

Eads & Heald Wealth Management grew its holdings in CVS Health Corp (NYSE:CVS) by 4.6% in the 1st quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 9,591 shares of the pharmacy operator’s stock after purchasing an additional 420 shares during the quarter. Eads & Heald Wealth Management’s holdings in CVS Health were worth $517,000 at the end of the most recent reporting period.

Other large investors have also bought and sold shares of the company. Inlet Private Wealth LLC raised its stake in shares of CVS Health by 106.6% during the 1st quarter. Inlet Private Wealth LLC now owns 40,175 shares of the pharmacy operator’s stock worth $2,167,000 after acquiring an additional 20,725 shares in the last quarter. Nicolet Bankshares Inc. raised its stake in shares of CVS Health by 104.0% during the 1st quarter. Nicolet Bankshares Inc. now owns 12,516 shares of the pharmacy operator’s stock worth $675,000 after acquiring an additional 6,382 shares in the last quarter. Enterprise Financial Services Corp raised its stake in shares of CVS Health by 16.8% during the 1st quarter. Enterprise Financial Services Corp now owns 4,810 shares of the pharmacy operator’s stock worth $259,000 after acquiring an additional 692 shares in the last quarter. Great Valley Advisor Group Inc. raised its stake in shares of CVS Health by 10.6% during the 1st quarter. Great Valley Advisor Group Inc. now owns 4,059 shares of the pharmacy operator’s stock worth $219,000 after acquiring an additional 390 shares in the last quarter. Finally, Reliance Trust Co. of Delaware raised its stake in shares of CVS Health by 0.9% during the 1st quarter. Reliance Trust Co. of Delaware now owns 27,890 shares of the pharmacy operator’s stock worth $1,504,000 after acquiring an additional 249 shares in the last quarter. Institutional investors and hedge funds own 77.29% of the company’s stock.

Several research analysts recently commented on the stock. CIBC reiterated a “market perform” rating on shares of CVS Health in a research note on Monday, April 15th. Raymond James cut their price target on shares of CVS Health from $90.00 to $75.00 and set a “strong-buy” rating on the stock in a research note on Thursday, April 18th. BMO Capital Markets initiated coverage on shares of CVS Health in a research note on Wednesday, April 10th. They set an “outperform” rating and a $58.00 price target on the stock. SunTrust Banks cut their price target on shares of CVS Health from $85.00 to $65.00 in a research note on Wednesday, April 10th. Finally, Guggenheim initiated coverage on shares of CVS Health in a research note on Thursday, April 18th. They set a “buy” rating and a $75.00 price target on the stock. Two research analysts have rated the stock with a sell rating, seven have assigned a hold rating, sixteen have issued a buy rating and one has assigned a strong buy rating to the company’s stock. The stock has an average rating of “Buy” and a consensus price target of $76.48.

Shares of CVS stock traded up $0.02 during trading hours on Wednesday, hitting $53.70. The company’s stock had a trading volume of 6,218,738 shares, compared to its average volume of 12,037,080. The stock has a 50 day simple moving average of $53.72. The stock has a market cap of $69.74 billion, a PE ratio of 7.58, a PEG ratio of 1.07 and a beta of 0.89. The company has a debt-to-equity ratio of 1.45, a quick ratio of 0.64 and a current ratio of 0.95. CVS Health Corp has a 12-month low of $51.72 and a 12-month high of $82.15.

CVS Health (NYSE:CVS) last released its quarterly earnings data on Wednesday, May 1st. The pharmacy operator reported $1.62 EPS for the quarter, beating the consensus estimate of $1.50 by $0.12. CVS Health had a negative net margin of 0.08% and a positive return on equity of 16.80%. The business had revenue of $61.65 billion for the quarter, compared to the consensus estimate of $60.39 billion. During the same period in the prior year, the firm earned $1.48 EPS. The business’s revenue for the quarter was up 34.8% on a year-over-year basis. Research analysts expect that CVS Health Corp will post 6.85 EPS for the current year.

CVS Health Company Profile

CVS Health Corporation provides health services and plans in the United States. Its Pharmacy Services segment offers pharmacy benefit management solutions, such as plan design and administration, formulary management, retail pharmacy network management, mail order pharmacy, specialty pharmacy and infusion, Medicare Part D, clinical, disease management, and medical spend management services.

Read More: Trading signals using Bollinger bands

Institutional Ownership by Quarter for CVS Health (NYSE:CVS)

Receive News & Ratings for CVS Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CVS Health and related companies with MarketBeat.com's FREE daily email newsletter.



Leave a Reply